
Andrew Bzowyckyj, PharmD, explains the transition to the 2021 CKD-EPI equation and its implications for medication decisions.

Andrew Bzowyckyj, PharmD, BCPS, CDCES, is the senior scientific director of Learning Consulting at the National Kidney Foundation.

Andrew Bzowyckyj, PharmD, explains the transition to the 2021 CKD-EPI equation and its implications for medication decisions.